NL Amsterdam Serlie MJ: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 1: Line 1:
{{MiPNetLab
{{MiPNetLab
|address=Serlie Mireille, MD PhD
|address=[[Serlie MJ|Serlie Mireille]], MD PhD


Academic Medical Center
Academic Medical Center
Line 14: Line 14:
1105 AZ Amsterdam, The Netherlands
1105 AZ Amsterdam, The Netherlands
|city=Amsterdam
|city=Amsterdam
|country=The Netherlands
|country=Netherlands
|MiPNetLab=Serlie MJ, Brand D, Brands M
|MiPNetLab=Serlie MJ, Brand D, Brands M
|Team previous=Sauerwein HP
|Team previous=Sauerwein HP
|info=IOC32
|info=[http://oroboros.at/index.php?id=ioc32-schroecken IOC32]
|keyword=Insulin resistance, obesity, fatty acids
|keyword=Insulin resistance, obesity, fatty acids
|keywords=Insulin resistance, obesity, fatty acids
|keywords=Insulin resistance, obesity, fatty acids
|Info=[http://www.oroboros.at/index.php?id=1255 NL_Amsterdam_SerlieMJ]
|Info=[http://www.oroboros.at/index.php?id=1255 NL_Amsterdam_SerlieMJ]
}}
}}

Revision as of 12:20, 3 August 2012

Cookies help us deliver our services. By using our services, you agree to our use of cookies.